The 36-month beta value for KLTO is also noteworthy at 0.02.
The public float for KLTO is 26.77M, and at present, short sellers hold a 1.93% of that float. The average trading volume of KLTO on June 23, 2025 was 38.05M shares.
KLTO) stock’s latest price update
The stock price of Klotho Neurosciences Inc (NASDAQ: KLTO) has jumped by 3225997 compared to previous close of 1.54. Despite this, the company has seen a fall of -18.13% in its stock price over the last five trading days. prnewswire.com reported 2025-06-18 that Key highlights of the announcement include: Elimination of Future Dilution: The Company will no longer be required to issue new common stock to SkyBell, which would have resulted in SkyBell owning 90% of the Company—substantially diluting existing shareholders. No Liability: Neither Klotho nor SkyBell will incur any liability as a result of the termination.
KLTO’s Market Performance
KLTO’s stock has fallen by -18.13% in the past week, with a monthly rise of 627.78% and a quarterly rise of 347.10%. The volatility ratio for the week is 4.99% while the volatility levels for the last 30 days are 50.50% for Klotho Neurosciences Inc The simple moving average for the last 20 days is 42.76% for KLTO’s stock, with a simple moving average of 186.50% for the last 200 days.
KLTO Trading at 176.17% from the 50-Day Moving Average
After a stumble in the market that brought KLTO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.41% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at KLTO starting from CHARDAN CAPITAL MARKETS LLC, who sale 180,000 shares at the price of $2.05 back on Jul 02 ’24. After this action, CHARDAN CAPITAL MARKETS LLC now owns 1,284,364 shares of Klotho Neurosciences Inc, valued at $368,442 using the latest closing price.
CHARDAN CAPITAL MARKETS LLC, the 10% Owner of Klotho Neurosciences Inc, sale 115,136 shares at $2.06 during a trade that took place back on Jul 01 ’24, which means that CHARDAN CAPITAL MARKETS LLC is holding 1,464,364 shares at $237,618 based on the most recent closing price.
Stock Fundamentals for KLTO
The total capital return value is set at -4.23. Equity return is now at value -131.50, with -68.33 for asset returns.
Based on Klotho Neurosciences Inc (KLTO), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -9.72. The debt to equity ratio resting at 0.23. The interest coverage ratio of the stock is -14.35.
Currently, EBITDA for the company is -5.79 million with net debt to EBITDA at -0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.29.
Conclusion
In summary, Klotho Neurosciences Inc (KLTO) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
